Ketamine, originally a battlefield anesthetic, is being explored for its potential in treating depression and anxiety, despite not being FDA approved for these uses. Concerns arise from the case of a well-known actor who developed an addiction to the drug, prompting questions about the ethics of off-label prescriptions. As mental health issues continue to escalate, the promise of ketamine as a revolutionary treatment raises both hope and skepticism among professionals.
